As policy dynamics accelerate across federal and state channels, manufacturers must prepare for multiple scenarios and align internal planning. Key readiness priorities for 2026.
See how a smarter coding strategy helped a medical device company strengthen payer alignment and accelerate access.
Magnolia Market Access released its fifth iteration of the IRA Payer Insights Survey in the summer of 2025 to understand how the IRA will affect the Medicare Part D program, including beneficiary premiums, formulary coverage, and contract negotiations for manufacturers and payers.
Design research payers can use: focus on real-world outcomes, durability, and total cost of care; bring payer input in early and often; and pressure-test access levers pre-launch. Turn strong science into coverage, reimbursement, and measurable ROI.
Find out how one manufacturer turned formulary complexity and policy uncertainty into strategic advantage using Magnolia Market Access’ Part D Formulary Databook.
As Medicare Part D plans adopt stricter utilization management, raise cost-sharing, and adjust tier placements, manufacturers face growing challenges in maintaining access. A data-driven formulary coverage assessment helps teams evaluate product positioning, benchmark competitors, and prepare for policy impacts — turning complexity into actionable strategy.
The Medicare Part D landscape is shifting fast. With IRA and H.R.1 driving formulary instability, manufacturers face rising deductibles, tighter utilization management, and new premium dynamics. Learn how Magnolia’s Part D Formulary Databook helps teams anticipate these changes and plan with confidence.
See how Magnolia Market Access helped a manufacturer overcome coding gaps, payer unfamiliarity, and site readiness challenges to launch the first FDA-approved therapy in a rare disease — creating a replicable, gold-standard access model.
Survey of 100 U.S. physicians uncovers key insights on how international HTA frameworks—especially Germany’s—undervalue chronic disease therapies. Explore the full infographic.
A small medical device company engaged Magnolia Market Access to strengthen its evidence strategy and value messaging for an innovative oncology device. Despite strong clinical results, the company needed to address evidence gaps and ensure its value story resonated with payers and providers.